Article info

Download PDFPDF
ASSA14-12-15 Efficacy and safety of direct thrombin inhibitor of bivalirudin during percutaneous coronary intervention therapy in AMI patients with Heparin-Induced Thrombocytopenia

Authors

  • Z Xin Department of Cardiology, Institute of Cardiovascular Research of People’s Liberation Army, Shenyang Northern Hospital, Shenyang, Liaoning 110840, China PubMed articlesGoogle scholar articles
  • W Li Department of Cardiology, Institute of Cardiovascular Research of People’s Liberation Army, Shenyang Northern Hospital, Shenyang, Liaoning 110840, China PubMed articlesGoogle scholar articles
  • D Yu-Yang Department of Cardiology, Institute of Cardiovascular Research of People’s Liberation Army, Shenyang Northern Hospital, Shenyang, Liaoning 110840, China PubMed articlesGoogle scholar articles
  • H Ya-Ling Department of Cardiology, Institute of Cardiovascular Research of People’s Liberation Army, Shenyang Northern Hospital, Shenyang, Liaoning 110840, China PubMed articlesGoogle scholar articles

Citation

Xin Z, Li W, Yu-Yang D, et al
ASSA14-12-15 Efficacy and safety of direct thrombin inhibitor of bivalirudin during percutaneous coronary intervention therapy in AMI patients with Heparin-Induced Thrombocytopenia

Publication history

  • First published December 1, 2014.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.